Status:
UNKNOWN
Clinical Study on Endoscopic Management of GOV1 Esophagogastric Varices
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborating Sponsors:
Jinhua Hospital Affiliated to Zhejiang University
Lanxi People's Hospital
Conditions:
Esophageal and Gastric Varices
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The patients with GOV1 esophagogastric varices will be treated with gastric variceal tissue gel injection, at the same time, the esophageal varices were treated with ligation, sclerotherapy, or no tre...
Detailed Description
Cirrhotic portal hypertension can cause esophageal and gastric varices, and esophageal and gastric varices bleeding (EGVB) were associated with portal vein pressure. At present, the gold standard for ...
Eligibility Criteria
Inclusion
- GOV1 esophageal and gastric varices identified by CT; more than 18 years old;
Exclusion
- Complicated with liver cancer, severe cardiopulmonary insufficiency, stage III and above hepatic encephalopathy, severe natural portal shunt formation, and previous treatment of portal hypertensive bleeding (including endoscopic, interventional, and surgical procedures).
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT05978752
Start Date
December 1 2023
End Date
November 1 2025
Last Update
August 24 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.